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The incidence  of  breast  cancer  has  been increasing  over  the  years. To  control  and  monitor  this disease
several  tumor  biomarkers  have  been  proposed  for early  diagnosis,  patient  follow-up  and/or  treatment
guidance.  The  only  serum  breast  cancer  biomarker  in current  use  is the  cancer  antigen  15-3 (CA  15-3).
In  this  work a  molecularly  imprinted  polymer  (MIP)-based  electrochemical  (voltammetric)  sensor  to
monitor  breast  cancer  was  developed,  based  on  direct  surface  imprinting  of  CA  15-3  on  a screen-printed
gold  electrode  (Au-SPE).  The  imprinting  was  performed  in  two steps:  (1) adsorption  of CA 15-3  on the
surface  of  the Au-SPE  and  (2) electropolymerization  of 2-aminophenol  around  the  adsorbed  protein.  After
extraction  of  the imprinted  protein  voltammetric  analysis  was  conducted  using  hexacyanoferrate(II/III)
as  redox  probe,  measuring  the  signals  before  and  after  protein  binding.  The  sensor  was characterized
by  voltammetric  techniques  and  electrochemical  impedance  spectroscopy,  and the  analytical  responses
of  imprinted  and non-imprinted  polymer  sensors  were  studied.  A  linear  relationship  between  the  peak
current  intensity  of  the  redox  probe  and  the  logarithm  of CA  15-3  concentration  was  established  between
5  and  50  U  mL−1,  achieving  a limit  of detection  of  1.5  U  mL−1.  The  prepared  MIP-sensor  provides  fast
(15  min)  analysis  and  is  cheap,  easy  to prepare,  disposable  and could  easily  be  integrated  in  small portable
point-of  care  devices.. Introduction
Cancer has been a constant challenge for science and medicine
nd is a major public health problem. In 2012, the International
gency for Research on Cancer (IARC) estimated that, worldwide,
here were 14.1 million new cancer cases, 32.6 million people were
iving with cancer (within 5 years of diagnosis) and 8.2 million peo-
le died from cancer [1]. The number of new cases is expected to rise
y about 70% over the next two decades [2]. Cancer is, as defined by
he World Health Organization (WHO), a generic term for a large
roup of diseases that can affect any part of the body. “One defin-
ng feature of cancer is the rapid creation of abnormal cells that
row beyond their usual boundaries, and which can then invade
djoining parts of the body and spread to other organs, the latter
rocess is referred to as metastasizing.” [2]. In metastasis, which is
he major cause of cancer death, cells lose their adhesion capacities
nd migrate to healthy tissues.
∗ Corresponding author.
E-mail address: jpgpa@isep.ipp.pt (J.G. Pacheco).Breast cancer, with 1.67 million new cases in 2012, ranks as the
second most common cancer and as the fifth most common cause of
death from cancer [3]. The development of screening programs and
improvements of treatment and follow-up have been able to lower
the mortality in the past few years, however it is still the leading
cause of cancer-related mortality in women [4]. Therefore, sev-
eral challenges still remain, including diagnosis, definition of high
risk recurrence population, early diagnosis of recurrence and guid-
ance through the different lines of treatment in the management
of metastatic disease [5]. Important research has been conducted
to identify suitable biomarkers of breast cancer, which has led to
advances in its detection and treatment [6]. These biomarkers can
be one of several substances that are produced by cancer cells, and
their levels can be monitored in tumor tissues or biological fluids
such as blood, urine, serum, plasma, stool, sputum or nipple dis-
charge. Many breast cancer biomarkers have been suggested, but
only CA 15-3 has been routinely adopted as a potential predictor of
treatment failure in the metastatic setting [4]. A decrease or return
to normal levels of this biomarker may  indicate that the cancer has
responded favorably to therapy [7–9].
Fig. 1. Schematic illustration of the construction and operation of the MIP/Au-SPE.
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Electrochemical molecularly imprinted polymer (MIP)-based
ensors, and especially the ones using voltammetric detection, can
e adequate tools because of their selectivity and sensitivity which
ould allow early detection of many diseases. Generally, MIPs are
btained by bulk (3-D) polymerization, a process in which selected
unctional monomers (either organic or inorganic materials) are
olymerized around a target analyte (template) in the presence of
 crosslinking agent. After polymerization, the template moleculeograms obtained after adsorption of different protein concentrations; (B) variation
after adsorption of different protein concentrations; (D) variation of the resistivity
is extracted and a polymer matrix, with sites complementary in
shape, size and functionality to the imprinted molecule, is obtained
[10,11]. Like this, MIPs show favored affinity towards the tem-
plate molecule compared to other molecules [11]. The advantages
of MIPs are their robustness, stability to changes in chemical and
thermal conditions, ease of preparation, reusability and low cost.
In principle, any molecule, from very small to macromolecules,
like proteins or even cells, can be subject to imprinting in dif-
Fig. 3. CV voltammograms recorded during the electropolymerization of 2-
aminophenol (10 mM in 0.1 M phosphate buffer pH 7.4). (A) NIP/Au-SPE and (B)
M
f
(
m
a
i
a
e
(
b
c
m
a
p
r
l
a
chemical techniques such as cyclic voltammetry (CV), differential
pulse voltammetry (DPV) and electrochemical impedance spec-IP/Au-SPE.
erent matrices [12]. Nevertheless, imprinting of macromolecules
like proteins) is problematic and challenging and its develop-
ent has been slower compared to the wide range of successful
pplications for small molecules [13]. Several problems have been
dentified in the molecular imprinting of proteins. These problems
re mainly related to their size (poor mass-transfer and permanent
ntrapment), complexity, conformational flexibility, and solubility
limited choice of solvent). Surface imprinting (2-D) has proven to
e a good approach for macromolecule imprinting. Using this pro-
edure thin film polymers, with good control of their thickness and
orphology, can be produced [14,15]. The imprinted binding sites
re located at or close to the surface of the MIPs, which solves the
roblems of restricted mass transfer, enabling easy extraction and
ebinding [14]. Although there are several reports about molecu-
arly imprinted polymer sensors for protein detection [16–18], few
re developed for cancer-related protein detection [19].In this work a voltammetric MIP  sensor for the analysis of CA
15-3 was  developed. The MIP  production was  based on direct
surface imprinting of the biomarker protein on the surface of a
screen-printed gold electrode (Au-SPE) using eletropolymeriza-
tion. The reduced size of the SPEs lowers the sample volume down
to 30–40 L, which is advantageous especially in the analysis of bio-
logical samples. Furthermore, SPEs can easily be integrated in small
pocket size electrochemical devices, which makes then attractive
to be used in point-of-care applications.
2. Experimental
2.1. Reagents
The breast cancer protein CA 15-3 was obtained from
MyBioSource. Guanidine hydrochloride, human serum from
male AB clotted whole blood, potassium phosphate monobasic,
potassium hexacyanoferrate(II) trihydrate, potassium hexacyano-
ferrate(III), proteinase K and oxalic acid anhydrous were supplied
by Sigma-Aldrich. Sulfuric acid from Panreac, 2-aminophenol from
ACROS, di-potassium hydrogen phosphate and acetic acid glacial
from Merck were also used. Throughout the work ultra-pure water
(resistivity = 18.2 M cm)  was  used. The CA 15-3 and hexacyano-
ferrate solutions were prepared in phosphate buffer (0.1 M,  pH 7.4).
2.2. Instrumentation
Voltammetric measurements were carried out using an Auto-
lab PGSTAT 204 potentiostat/galvanostat (Metrohm Autolab) and
electrochemical impedance spectroscopic (EIS) analysis were
performed using an Autolab PGSTAT 128N (Metrohm Auto-
lab). The equipment was  controlled by NOVA software (version
1.11, Metrohm Autolab). Screen-printed gold electrodes (Au-SPE,
DropSens, DRP-C223BT) with gold working (d = 1.6 mm)  and auxil-
iary electrodes and a silver reference electrode were used.
2.3. MIP/NIP construction
The optimized procedure for the MIP  preparation was  as fol-
lows: after the activation of the Au-SPE with 0.5 M H2SO4 (applying
5 cyclic voltammetric scans; potential range: −0.2 V to +1.3 V,
scan rate: 100 mV  s−1), 2 L of a CA 15-3 solution (50 U mL−1)
was placed on the working electrode of the Au-SPE and left to
incubate (20 min). After gently rinsing the Au-SPE with a 0.1 M
phosphate buffer (pH 7.4) and subsequent drying, 40 L of a
10 mM 2-aminophenol solution was placed on the Au-SPE and
the electropolymerization was performed (10 cyclic voltammet-
ric scans; potential range: −0.1 V to +0.9 V, scan rate: 100 mV s−1).
The polymerization solution was then replaced with 40 L of 0.1 M
phosphate buffer (pH 7.4) and an additional 5 cyclic voltammetric
scans, using the same parameters as before, were applied to remove
unpolymerized monomer residues and to stabilize the polymer.
Finally, the protein was removed from the imprinted polymer by
placing 0.5 M oxalic acid (12 h) and 0.1 M phosphate buffer (1 h) on
the Au-SPE. A control electrode (non-imprinted polymer, NIP) was
also prepared. The procedure for the preparation of this NIP was
the same as for the MIP  but no CA 15-3 was used in this case.
2.4. Electrochemical detection
The interactions between CA 15-3 and the MIP  and NIP were
evaluated using a redox probe (5 mM [Fe(CN)6]3−/4− (1:1)). Electro-troscopy (EIS) were used to characterize the MIP/NIP during the
construction and optimization processes. The potential range in
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ahe CV was between −0.2 V and +0.6 V (6 scans at a scan rate of
0 mV s−1), and the potential range in DPV was between −0.2 V
nd +0.5 V (pulse amplitude: 50 mV,  step potential: 2.5 mV). In EIS,
 sinusoidal signal with a 10-mV amplitude and a fixed potential of
.2 V was applied in a frequency range between 0.1 and 10.000 Hz
ith 50 frequencies distributed logarithmically.
.5. Sample preparation
First aliquots of human serum were spiked with different CA 15-
 concentrations and were then diluted (1:1) with 0.1 M phosphate
uffer (pH 7.4). The resulting solutions were analyzed directly using
he above-mentioned electrochemical techniques.
. Results and discussion
.1. Construction and operation of the sensor
The overall process of the preparation of the MIP  (Fig. 1) con-
isted of 3 different stages: (1) CA 15-3 immobilization through
dsorption on the working electrode of the Au-SPE; (2) imprint-
ng by forming a thin polymer film, through electropolymerization,
round the adsorbed protein; (3) protein removal and creation of
elective cavities in the polymeric film.
Preliminary voltammetric tests showed that CA 15-3 was not
lectrochemically active (i.e. no oxidation/reduction peaks were
bserved) at the Au-SPE. Therefore, the analyses were conducted
sing [Fe(CN)6)]3−/4− as redox probe, measuring the differences
etween the signals before and after protein binding. The use of the
ensor for CA 15-3 analysis consisted of 4 steps (Fig. 1): (4) mea-
urement of the [Fe(CN)6)]3−/4− signal when the polymeric cavities
re unoccupied (after extraction); (5) incubation of the MIP/Au-SPE
n CA 15-3 standard or sample solutions for a defined time; (6) mea-
urement of the [Fe(CN)6)]3−/4− signal  after incubation, when the
olymeric cavities are partiality occupied; (7) regeneration of the
ensor by extracting CA 15-3 from the polymer.
.1.1. CA 15-3 adsorption
To  test the adsorption of CA 15-3 on conventional glassy carbon
nd gold electrodes, a solution of the protein was dropped on the
urfaces of these electrodes. Based on the measurements of the
ignal of the redox probe before and after protein deposition it was
bserved that CA 15-3 did not adsorb on the glassy carbon surface
ut adsorbed on the gold surface.
To study the possible immobilization of CA 15-3 on the Au-
PE, 3 L of CA 15-3 solutions (0–100 U mL−1) were placed on the
orking electrode of the Au-SPE for 20 min. Before and after the
mmobilization approach DPV and EIS analysis were performed
Fig. 2). In the DPV analysis (Fig. 2A and B) a marked decrease of
he peak current intensity (ip) was observed for protein concen-
rations between 0–25 U mL−1. For higher concentrations (50 and
00 U mL−1) the ip remained constant. In the EIS analysis (Fig. 2C
nd D) an increase of the resistivity with the increase of protein
oncentration up to 50 U mL−1 was  found. Therefore, it could be
oncluded that CA 15-3 was successfully adsorbed on the electrode.
ased on these results a CA 15-3 concentration of 50 U mL−1 was
elected for the preparation of the MIP.
.1.2. Molecular imprinting of CA 15-3
After the successful adsorption of the protein on the Au-SPE
he molecular imprinting was performed by electropolymerization
sing 2-aminophenol as functional monomer. A 50-L aliquot of a
0 mM 2-aminophenol solution (in phosphate buffer 0.1 M pH 7.4)
as placed on the Au-SPE and 10 consecutive cyclic voltammetric
ycles between −0.1 V to +0.9 V were applied. A control NIP was
lso prepared using the same conditions, but without the proteinFig. 4. Analysis of NIP/Au-SPE and MIP/Au-SPE after polymerization using 5 mM
[Fe(CN)6)]3−/4− .  (A) DPV voltammograms and (B) EIS Nyquist diagrams.
adsorption step. The CVs corresponding to the preparation of the
MIP  and the NIP are shown in Fig. 3. There are clear differences
between the electropolymerizations of the MIP  and the NIP. In the
NIP polymerization process the oxidation peak of 2-aminophenol
was only observed during the first potential cycle. This indicated
the formation of a nonconductive polymeric film at the surface of
gold working electrode. In the MIP  polymerization process the oxi-
dation peak of 2-aminophenol was also observed during the first
cycle, but a slower decrease of this peak was observed during the
following cycles. This behaviour can be attributed to the presence
of protein adsorbed on the surface of the gold working electrode,
which slows the formation of the non-conductive polymer.
The  prepared MIP  and NIP were analyzed by DPV and EIS imme-
diately after polymerization using a 5 mM [Fe(CN)6)]3−/4− solution
(Fig. 4). It can be confirmed that non-conductive polymer films were
prepared with clear differences between the MIP  and the NIP. The
DPV analysis of the NIP showed a low ip of  the redox probe while
the EIS analysis revealed a high resistivity. However, for the MIP
no oxidation peak was  observed and a much higher resistivity was
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Fig. 6. Characterization of the step by step construction of the MIP/Au-SPE sensor.
(A) CV voltammograms and (B) EIS Nyquist diagrams in 5 mM [Fe(CN)6)]3−/4− andig. 5. Evaluation of the protein extraction using different solvents. (A) CV voltam-
ograms  and (B) EIS Nyquist diagrams obtained in 10 mM [Fe(CN)6)]3−/4− and
hosphate buffer 0.1 M pH 7.
btained. These results confirmed that the protein was successfully
mprinted and entrapped in the polymeric film.
.1.3. Protein extraction
An  important step in the preparation of a MIP  is the extraction
f the template molecule after polymerization to create the specific
inding cavities. The entrapped template molecules can be difficult
o remove and is a problem that is frequently encountered in pro-
ein imprinting due to the size and complex structure of proteins.
herefore it is necessary to study the conditions that guarantee
heir efficient removal, which is most commonly accomplished by
olvent extraction. For this purpose, and besides water, several
queous extraction solutions were tested: 1% acetic acid + 1% SDS;
.5 M oxalic acid; 0.5 M guanidine, and 0.5 M proteinase K solutions.
ive MIP  sensors were prepared and after polymerization each of
hem was exposed to a different extraction solution overnight. Then
he sensors were placed in phosphate buffer (0.1 M,  pH 7.4) for one
our and the extraction efficiency was evaluated comparing the CV
nd EIS analysis of the sensor before and after exposure to the sol-0.1 M phosphate buffer 0.1 M pH 7.
vents (Fig. 5). In the case of water no significant differences between
the CV and EIS results before and after its use were observed. This
indicates that the protein could not be extracted with water. In the
case of the guanidine and proteinase K solutions, small variations
in the CV analysis were seen, but no oxidation/reduction peak was
obtained. In the EIS analysis a more pronounced difference was
observed, but the resistivity remained high. The major differences
were achieved using the acidic solutions. For both of them oxida-
tion/reduction peaks in the CV analysis and a much lower resistivity
in the EIS were observed after the extraction of the protein. These
results can be attributed to the efficient extraction of the protein,
and thus the formation of the specific cavities in the film. These cav-
ities allow [Fe(CN)6)]3−/4− to reach the surface of electrode which
in turn results in oxidation/reduction peaks. The solution contain-
ing oxalic acid was chosen as extraction solvent since it produces
the highest difference in the responses before and after extraction.
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f  the peak current intensity for MIP  sensor with the concentration; (C) DPV voltam
D) variation of the peak current intensity for NIP sensor with the concentration.
.2. Sensor characterization
During each step of the construction of the MIP and its subse-
uent use, the sensor was characterized by CV and EIS using 5 mM
Fe(CN)6)]3−/4− (Fig. 6). In EIS the semicircle of the Nyquist diagram
or higher frequencies corresponds to the electron transfer process
hile the linear part of the lower frequency corresponds to diffu-
ion. In Fig. 6(A) the straight line for the Au-SPE corresponds to a
iffusion limited process with fast electron transfer kinetics. After
he adsorption of CA 15-3 there is an increase of the semicircle,
ndicating a blocking effect caused by the presence of the protein
hat results in the reduction of electron transfer and an increase of
he resistance to the electron flow. After polymerization there was
 high increase of the impedance and the surface was highly resis-
ant to electron transfer due to the formation of the polymer film
ontaining the entrapped protein. After protein extraction a high
ecrease of the impedance was observed. This can be explained
y the formation of cavities after protein removal, improving the
iffusion of [Fe(CN)6]3−/4− through the polymer which facilitates
he electron transfer electrons. Finally, after the incubation of the
rotein again a slight increase of the semicircle occurred, which
ndicates that the protein was successfully bound to the MIP  and
ccupied some of the selective cavities. for MIP  sensor after incubation with different protein concentrations; (B) variation
ms obtained for NIP sensor after incubation with different protein concentrations;
Similar behaviors were observed in the CV analyses (Fig. 6(B)).
Two well defined redox peaks were observed for the unmodified
Au-SPE. After protein adsorption, a slight decrease of the peak cur-
rent intensities occurred. After polymerization no redox peaks were
obtained. This is a result of the blockage of the electron transfer by
the polymer. After protein extraction the redox peaks once again
appeared, indicating the efficiency of the extraction. As mentioned
before, the extraction of the protein from the polymer creates cav-
ities that increase the porosity of the MIP, which facilitates the
diffusion of [Fe (CN)6]3−/4− to  the electrode surface and the occur-
rence of the redox reaction. Finally, after incubation of the MIP
sensor with the protein a decrease of the redox peaks was  regis-
tered. This can be explained by the fact that the CA 15-3 molecules
fill the cavities that block the diffusion of [Fe(CN)6]3−/4−. It should
be noted that there is a large difference in the EIS and CV analysis
between unmodified Au-SPE and MIP/Au-SPE after extraction.
3.3. Analytical responseThe analytical response of both the MIP  and NIP sensors
was tested. Solutions with different concentrations of CA 15-3
(5–50 U mL−1) were incubated during 10 min and a DPV voltam-
mogram was recorded (Fig. 7).
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aig. 8. Variation of ip with the logarithm of the CA 15-3 concentration for the
IP/Au-SPE  and NIP/Au-SPE sensors.
A decrease of the ip of  the redox probe was observed with the
ncrease of the CA 15-3 concentration for both the MIP  and NIP
ensors. These results indicated that both sensors responded to
ariations of the CA 15-3 concentration. However, the decrease of
he ip is more pronounced in MIP  sensor. Therefore, the MIP  sensor
rovides a much better sensitivity.
These results were used to construct calibration curves by
lotting the current variation (ip before  incubation − ip after  incu-
ation) as a function of the logarithm of the CA 15-3 concentration
Fig. 8). The variation of the ip of the redox probe was linearly
roportional to the logarithm of concentration of CA 15-3 in the
ested range. The linear regression equation for the MIP  sensor was
p (A)  = 5.33 × log[CA 15-3] (U mL−1) − 1.26 (r = 0.9984) and for the
IP sensor ip (A) = 1.44 × log [CA 15-3] (U mL−1) + 0.28 (r = 0.9646).
The  limit of detection (LOD) was calculated using the following
quation: LOD = 3 s/m, where “s” is the standard deviation of the
ntercept and “m”  is the slope of the calibration plot. The limit of
etection (LOD) for the MIP  sensor was estimated to be 1.5 U mL−1.
.4. Selectivity studies
Another breast cancer biomarker, the extracellular domain of
he human epidermal growth factor receptor 2 (HER2-ECD), and
 biomarker of kidney function cystatin C (CC) were selected to
tudy the selectivity of the MIP  sensor. Both are proteins that are
maller in size than CA 15-3. Solutions of these proteins were pre-
ared in phosphate buffer with concentrations of 15 ng mL−1 and
70 ng mL−1 for  HER2-ECD and CC, respectively. The responses of
he MIP  sensor to these proteins were studied and the results were
ompared with the MIP  sensor’s response to a solution of CA 15-3
0 U mL−1 (Fig. 9). The peak current variation for HER2-ECD and CC
orresponded to 55 and 24% of the CA 15-3 peak variation, respec-
ively. This indicates that HER2-ECD could have some interference
n the analysis.
.5. Detection of CA 15-3 in human serum samples
To validate its usefulness in complex samples, the MIP/Au-SPE
ensor was applied to the detection of CA 15-3 in spiked human
erum. For this purpose serum samples were spiked with three dif-
−1erent protein concentrations: 10, 30 and 50 U mL . Recoveries of
2, 82 and 87% with relative standard deviations (RSD, %, n = 3) of
, 9 and 9% were obtained, respectively. These results proved the
bility of the proposed sensor to be used as a fast, cheap, and easy toFig. 9. Selectivity studies.
perform method for CA 15-3 analysis in biological samples without
the need of laborious pre-treatment steps or methods.
4. Conclusions
In this work a gold screen-printed gold electrode was modi-
fied with a molecularly imprinted polymer for the detection of the
breast cancer biomarker CA 15-3. A linear relationship between the
peak current intensity of the hexacyanoferrate redox probe and the
logarithm of the CA15-3 concentration was established between 5
and 50 U mL−1. The attained detection limit of 1.5 U mL−1 is  well
below the used cut-off value in clinical practice (25 U mL−1). There-
fore, the developed sensor is promising for its use in the clinical
setting. Besides this, the MIP  sensor is an excellent candidate to
be included in point-of-care devices because of the short analysis
time (15 min) and, its simplicity and low cost, which could be very
important in the monitoring of the patient’s response to treatment
and/or to evaluate the recurrence/progression of the cancer.
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